96 related articles for article (PubMed ID: 7561189)
1. Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly.
Powers DC; Manning MC; Hanscome PJ; Pietrobon PJ
J Infect Dis; 1995 Oct; 172(4):1103-7. PubMed ID: 7561189
[TBL] [Abstract][Full Text] [Related]
2. Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults.
Powers DC
Mech Ageing Dev; 1997 Feb; 93(1-3):179-88. PubMed ID: 9089582
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).
Ennis FA; Cruz J; Jameson J; Klein M; Burt D; Thipphawong J
Virology; 1999 Jul; 259(2):256-61. PubMed ID: 10388649
[TBL] [Abstract][Full Text] [Related]
4. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant.
Powers DC; Hanscome PJ; Pietrobon PJ
Vaccine; 1995 Oct; 13(14):1330-5. PubMed ID: 8585289
[TBL] [Abstract][Full Text] [Related]
5. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
Powers DC; Belshe RB
J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
Mbawuike IN; Piedra PA; Cate TR; Couch RB
J Med Virol; 1996 Oct; 50(2):105-11. PubMed ID: 8915874
[TBL] [Abstract][Full Text] [Related]
7. Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women.
Powers DC
Clin Diagn Lab Immunol; 1994 Jan; 1(1):16-20. PubMed ID: 7496915
[TBL] [Abstract][Full Text] [Related]
8. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
[TBL] [Abstract][Full Text] [Related]
9. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age.
Powers DC
J Am Geriatr Soc; 1993 Jan; 41(1):1-5. PubMed ID: 8418115
[TBL] [Abstract][Full Text] [Related]
10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
[TBL] [Abstract][Full Text] [Related]
12. Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A.
Mbawuike IN; Acuna C; Caballero D; Pham-Nguyen K; Gilbert B; Petribon P; Harmon M
Cell Immunol; 1996 Oct; 173(1):64-78. PubMed ID: 8871602
[TBL] [Abstract][Full Text] [Related]
13. Development of a cytotoxic T-lymphocyte-based, broadly protective influenza vaccine.
Uchida T
Microbiol Immunol; 2011 Jan; 55(1):19-27. PubMed ID: 21175770
[TBL] [Abstract][Full Text] [Related]
14. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine.
Gorse GJ; Campbell MJ; Otto EE; Powers DC; Chambers GW; Newman FK
J Infect Dis; 1995 Jul; 172(1):1-10. PubMed ID: 7797897
[TBL] [Abstract][Full Text] [Related]
15. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.
Gorse GJ; Belshe RB
J Clin Microbiol; 1990 Nov; 28(11):2539-50. PubMed ID: 2123886
[TBL] [Abstract][Full Text] [Related]
17. The human cytotoxic T cell response to influenza A vaccination.
McMichael AJ; Gotch F; Cullen P; Askonas B; Webster RG
Clin Exp Immunol; 1981 Feb; 43(2):276-84. PubMed ID: 6974066
[TBL] [Abstract][Full Text] [Related]
18. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons.
Mbawuike IN; Lange AR; Couch RB
Viral Immunol; 1993; 6(1):55-64. PubMed ID: 8476508
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML
J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
[TBL] [Abstract][Full Text] [Related]
20. Induction of lung CD8
Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
